simvastatin has been researched along with Hyper IgD Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beekman, JM; Coffer, PJ; Frenkel, J; Koster, J; Kuijk, LM; Waterham, HR | 1 |
| Attout, H; Guez, S; Jameerbaccus, N; Ranaivo, I; Series, C | 1 |
| Henneman, L; Schneiders, MS; Turkenburg, M; Waterham, HR | 1 |
| Carlucci, JG; Edwards, KM; Wurster, VM | 1 |
1 review(s) available for simvastatin and Hyper IgD Syndrome
| Article | Year |
|---|---|
Periodic Fever syndromes.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Child; Colchicine; Cryopyrin-Associated Periodic Syndromes; Cytokines; Diagnosis, Differential; Familial Mediterranean Fever; Fever; Hereditary Autoinflammatory Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Lymphadenitis; Mevalonate Kinase Deficiency; Neutropenia; Pharyngitis; Prednisone; Recombinant Fusion Proteins; Recurrence; Simvastatin; Stomatitis, Aphthous; Syndrome | 2011 |
3 other study(ies) available for simvastatin and Hyper IgD Syndrome
| Article | Year |
|---|---|
HMG-CoA reductase inhibition induces IL-1beta release through Rac1/PI3K/PKB-dependent caspase-1 activation.
Topics: Base Sequence; Caspase 1; Cell Line; DNA Primers; Enzyme Activation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Lipopolysaccharides; Mevalonate Kinase Deficiency; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; Signal Transduction; Simvastatin | 2008 |
A patient with hyper-IgD syndrome responding to simvastatin treatment.
Topics: Adult; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonate Kinase Deficiency; Simvastatin; Treatment Outcome | 2008 |
Compromized geranylgeranylation of RhoA and Rac1 in mevalonate kinase deficiency.
Topics: Case-Control Studies; Cell Line; Cell Membrane; Enzyme Activation; Fibroblasts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonate Kinase Deficiency; Phosphotransferases (Alcohol Group Acceptor); Protein Prenylation; Protein Transport; rac1 GTP-Binding Protein; rhoA GTP-Binding Protein; Signal Transduction; Simvastatin | 2010 |